Literature DB >> 15933579

Experience with oseltamivir for infants younger than 1 year old in Japan.

Shigeru Okamoto, Ichiro Kamiya, Kenji Kishida, Tetsuro Shimakawa, Tsuguya Fukui, Takeshi Morimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15933579     DOI： 10.1097/01.inf.0000164799.33635.fe

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  19 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  During influenza season, which children need an antiviral and which one should I prescribe? Do I need to verify that they have influenza first?

Authors:  M Bowman; Se Forgie
Journal:  Paediatr Child Health       Date:  2010-10       Impact factor: 2.253

3.  Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health.

Authors: 
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

4.  The use of antiviral drugs for influenza: recommended guidelines for practitioners.

Authors:  Upton D Allen; Fred Y Aoki; H Grant Stiver
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

5.  Oseltamivir dosing in premature infants.

Authors:  Christopher McPherson; Barbara Warner; David A Hunstad; Alexis Elward; Edward P Acosta
Journal:  J Infect Dis       Date:  2012-07-17       Impact factor: 5.226

Review 6.  Antivirals for influenza: strategies for use in pediatrics.

Authors:  Steven M Smith; John G Gums
Journal:  Paediatr Drugs       Date:  2010-10-01       Impact factor: 3.022

Review 7.  Use of oseltamivir in children.

Authors:  Blake Jamieson; Rini Jain; Bruce Carleton; Ran D Goldman
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

Review 8.  Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.

Authors:  Matthew Shun-Shin; Matthew Thompson; Carl Heneghan; Rafael Perera; Anthony Harnden; David Mant
Journal:  BMJ       Date:  2009-08-10

9.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

10.  Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.

Authors:  David W Kimberlin; Marwan Shalabi; Mark J Abzug; David Lang; Richard F Jacobs; Gregory Storch; John S Bradley; Kelly C Wade; Octavio Ramilo; José R Romero; Mark Shelton; Charles Leach; Judith Guzman-Cottrill; Joan Robinson; Nazha Abughali; Janet Englund; Jill Griffin; Penny Jester; Gretchen A Cloud; Richard J Whitley
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.